Immunic, Inc.
IMUX· Nasdaq
Released Nov 3, 2022, before the open
10-Q filed Nov 3, 2022, 34 days after period end · 0001280776-22-000021
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Net Income | -$21.22M | -$19.29M | -$12.91M | -$8.22M |
| EPS Diluted | -$0.69 | -$0.76 | -$0.70 | -$0.82 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR